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Inil for integration?
The newly discovered Inil cellular protein binds HIV-1 integrase and is
part of a protein complex thought to alter nucleosomal structure; such
alterations may influence the selection of sites for HIV-1 DNA integration.
Many gene therapy protocols use retroviruses to deliver
correCtive genes to diseased cells, primarily because
retroviral infection culminates in the covalent insertion of
reverse-transcribed retroviral DNA into host cell chro-
mosomes. This DNA integration ensures that the thera-
peutic gene will be maintained indefinitely in the target
cells. But retroviral DNA integration can also adversely
influence host genes; examples of potentially harmful
effects include the insertional inactivation of a host gene,
inappropriate transcriptional activation of a nearby gene,
and the creation of a novel fusion protein by joining a
viral exon to a nearby host exon [1]. It is well-docu-
mented that such lesions can lead to problems as severe as
transformation of the host cell. At present, there is no
way to control the site of retroviral integration in vivo, so
if large numbers of cells are infected during gene therapy,
the chance of a harmful integration event occurring
becomes uncomfortably high. Recently, several reports
have indicated that it may be possible to control integra-
tion-site selection in vivo and so to restrict integration to
'safe' sites in the host DNA.
In one of these studies, Kalpana et al. [2] used the yeast
two-hybrid genetic-interaction screening method to
search for cellular proteins that might participate in retro-
viral DNA integration. As 'bait' they used the HIV-1
integrase protein, which forms the initial covalent con-
nection between the retroviral cDNA and the host DNA.
Their screen yielded a cDNA clone encoding a protein
that binds specifically to integrase both in vivo and in vitro.
The integrase-binding protein, designated Inil (inte-
grase-interacting protein 1), had not been described pre-
viously, but displays a high degree of sequence similarity
to the yeast protein Snf5, a factor that is implicated in the
transcriptional activation of a number of genes.
To ask what function Inil might serve during HIV-1
integration, Kalpana et al. [2] tested the effect of adding
purified Inil-glutathione-S-transferase fusion protein to
an in vitro assay for the DNA-joining activity of HIV-1
integrase. They found that, at certain concentrations, the
Inil fusion protein increased the efficiency of integra-
tion. This effect was also seen using cytoplasmic extracts
enriched for Inil, but not with extracts that had been
depleted of Inil by affinity chromatography, suggesting
that the cellular Inil protein functions in a similar way
to the fusion protein that was produced in bacteria.
However, other small nucleic-acid-binding proteins that
are not thought to bind specifically to the integration
machinery can also boost integration efficiency in this
assay [3], so the results in vitro must be interpreted with
caution. Nevertheless, the observation of these activities,
together with the sequence similarity to yeast Snf5,
makes a provocative case that Inil has a role in HIV-1
DNA integration.
If Inil binds to DNA, it might serve as a protein bridge
that moors the retroviral integration machinery to the
host DNA, possibly directing integration to desired sites
(Fig. la), as suggested by Kalpana and Goff [2]. Indeed,
such a mechanism has a precedent in the behavior of the
yeast retrotransposon Ty3, which transposes by reverse
transcription of Ty3 mRNA and integration of the
resulting cDNA at a different site in the same cell. These
steps are performed by Ty3-encoded reverse transcriptase
and integrase proteins that are homologous to those of
retroviruses. The Ty3 life-cycle is thus biochemically
similar to that of a retrovirus, except that it does not have
an extracellular phase. Unlike retroviruses, however, Ty3
integrates at specific sites, always within five base pairs of
the transcriptional start site of genes transcribed by RNA
polymerase III. As DNA insertion upstream of poly-
merase III transcription units has little impact on the
health of the cell, Ty3 probably evolved this mechanism
to avoid insertional mutagenesis of genes that are neces-
sary for the survival of its host. Genetic studies have
shown that efficient Ty3 targets require intact binding
sites for the basal transcription factors TFIIIB and
TFIIIC. Transcription itself is not required, however,
suggesting that tethering of the Ty3 integration machin-
ery to the polymerase III transcription complex mediates
selective integration [4].
The findings with Ty3 indicated that artificially tethering
retroviral integration machinery to a specific DNA se-
quence might force the retroviral DNA to integrate at a
chosen site, and a recent study confirmed this prediction
in vitro [5]. The gene encoding HIV-1 integrase (IN) was
fused to DNA encoding the sequence-specific DNA-
binding domain of the bacteriophage repressor (R).
The XR-IN-encoded fusion protein directed integration
in vitro selectively into DNA fragments containing oper-
ators (binding sites for the repressor protein). An analy-
sis of the integration sites that were used showed that
integration occurred predominately into sequences with-
in 100 base-pairs of the operators and on the same face of
the DNA helix as the operators; little or no integration
took place in the operator sites themselves. These results
suggested that the R protein domain bound operator
sequences, thereby tethering the integrase protein domain
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Fig. 1. Models for Inil function in HIV-1 integration. Three non-exclusive possibilities are shown. Drawings are for example only, and
no specific spatial relationship of DNA and protein components is implied.
to the operators and promoting integration into adjacent
sequences. Thus, XR-IN achieved the goal of directing
selective integration. Ty3 and XR-IN each provide an
example of how integration can be directed near specific
DNA sites by tethering, and the binding of the HIV-1
integrase protein domain to the Inil protein could be
yet another example. Although XR-IN-mediated inte-
gration was selective, the sites used were distributed over
longer stretches of DNA than those used by. Ty3. It is
not known why Ty3 displays such remarkable specificity
relative to XR-IN, but possible explanations include
different arrangements of integrase monomers, the in-
volvement of additional proteins, and the presence in
Ty3 targets of unusual DNA structures, such as kinks or
other distortions.
The efficiency of retroviral DNA integration depends
strongly on the structure of the target DNA. For exam-
ple, a naked DNA molecule with an intrinsic curve is a
better integration target than a naked DNA molecule with
a rigid or flexible structure, and all DNAs so far studied
become more efficient integration targets when incorpo-
rated into nucleosomes [6-8]. The latter phenomenon is
attributable to the change in DNA structure that occurs
when DNA is wrapped around a histone octamer: in
order to maintain contact with the histones, the DNA
helical axis changes direction sharply at two sites per
nucleosome, thereby introducing kinks into the DNA
[9]. Integration is highly favored at these kinked sites [7],
and indeed at other sites of DNA distortion [10].
Inil might also function as more than a simple tether dur-
ing HIV-1 DNA integration. The apparent yeast homolog
of Inil, Snf5, is one of at least five proteins in the Swi/
Snf complex. Genetic studies in yeast have implicated this
complex as being important for transcriptional activation
of a large number of genes (for a recent review, see [11]).
Potentially homologous complexes are also found in
human cells, and Inil is probably a member of this com-
plex, as the Inil integrase-stimulating activity can be
removed from extracts using an antibody against another
component of the complex. Purified Swi/Snf complexes
from yeast and human cells were recently reported to
alter the structure of nucleosomal DNA in vitro so as to
promote the binding of sequence-specific transcriptional
control proteins [12-14], a function that may begin to
explain the ability of Swi/Snf proteins to influence the
transcription of a diverse set of genes in vivo. It is not yet
understood how Swi/Snf complexes alter the nucleo-
somal structure, but the remodeling that does occur is
accompanied by dramatic changes in DNA topology [13]
that might promote integration. But there seems to be a
paradox: packaging DNA into nucleosomes makes it a
better integration target, yet the integration machinery
apparently interacts with a component of the Swi/Snf
complex, which is thought to disrupt nucleosomes.
How can these observations be reconciled? Kalpana and
Goff [2] suggest that contact between Inil and integrase
may stimulate the DNA-joining activity of the inte-
grase, consistent with the observed stimulation of inte-
gration by Inil in vitro (Fig. lb). If nucleosomes mo-
dified by the Swi/Snf complex really are less attractive
integration targets than unmodified nucleosomes, the
stimulation of integrase activity by Inil might never-
theless result in a net increase in integration. However,
370 Current Biology 1995, Vol 5 No 4
integration into nucleosomes altered by the Swi/Snf
complex has not been studied, so it is also possible that
nucleosomal DNA becomes an even better target under
the influence of the Swi/Snf complex (Fig. c). Perhaps
the nucleosome alterations that are generated by the
Swi/Snf complex serve to unfold higher-order chromatin
structures (for example, 30 nm chromatin fibers) and so
to make nucleosomal targets more accessible. As purified
human Swi/Snf complexes and purified HIV-1 preinte-
gration complexes are now available, these possibilities
can be tested.
The discovery that the HIV-1 integration machinery can
bind to a cellular protein provides a new avenue for the
study of target-site selection during HIV-1 integration.
Together with recent advances towards directing HIV-1
integration to specific DNA sequences in vitro and in
understanding how Ty3 integrates at specific positions
in vivo, this finding offers hope that we may be able to
influence integration-site selection during retroviral infec-
tion. Ultimately, retroviral vectors might be designed to
integrate at predetermined DNA sites in vivo, making
them safer for the delivery of DNA sequences in gene
therapy. Perhaps such vectors could also be designed for
insertional inactivation of a harmful gene, such as an acti-
vated oncogene, bringing a new degree of flexibility to
human gene manipulation.
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